Benign prostatic hyperplasia treatment using plasmonic nanoparticles irradiated by laser in a rat model
Author:
Funder
Shiraz University of Medical Sciences
Persian Gulf Biomedical Research Center
Bushehr University of Medical Sciences
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference31 articles.
1. Lower urinary tract symptoms, benign prostatic hyperplasia, and urinary retention;Alawamlh;Med. Clin.,2018
2. Guidelines for the treatment of benign prostatic hyperplasia;Davidian;US Pharm,2016
3. Current pharmacological treatment for male LUTS due to BPH: dutasteride or finasteride?;Pirozzi;Curr. Drug Targets,2015
4. Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis;Carnevale;Cardiovasc. Intervent. Radiol.,2016
5. Near-infrared light-activatable microneedle system for treating superficial tumors by combination of chemotherapy and photothermal therapy;Chen;ACS Nano,2015
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of Thyroid Gland Sonography Index with Serum Antithyroid Peroxidase, Antithyroglobulin, and Thyroid Function Tests in Patients with Hashimoto Thyroiditis;Galen Medical Journal;2024-07-28
2. A review of the role of carbon nanotubes for cancer treatment based on photothermal and photodynamic therapy techniques;Journal of Organometallic Chemistry;2023-10
3. Comparative effects of finasteride and laser-irradiated silver nanoparticles on testicular function and histology in testosterone induced benign prostatic hyperplasia in rats;Life Sciences;2023-07
4. Advanced methylene blue — nanoemulsions for in vitro photodynamic therapy on oral and cervical human carcinoma;Lasers in Medical Science;2022-07-12
5. Photothermal therapeutic potency of plasmonic silver nanoparticles for apoptosis and anti-angiogenesis in testosterone induced benign prostate hyperplasia in rats;Life Sciences;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3